Companies: 10,795·Total market cap: $144.5T
Context Therapeutics Inc.

Context Therapeutics Inc.

CNTXNASDAQHealthcare● Active
$1.71
$-0.04(-2.29%)
Market Cap$157113393
P/E Ratio—
52W High$3.62
52W Low$0.56
SEC Filings

Context Therapeutics Inc. (CNTX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001842952 · CNTX · NASDAQ · as of Jun 9, 2026

Filing snapshot

292
Total Filings
8-K
Latest Form
2026-05-18
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001842952 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-23
Fiscal Year End
Mar 23, 2026
Accession No.
0001628280-26-020498
Primary Document
cntx-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001842952 · Accession 0001628280-26-020498

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-06
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-18Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-18
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-14
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-12
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-08
View
10-QQuarterly Report
10-Q
2026-05-06
View
8-KCurrent Report
8-K
2026-05-01
View
ARSARS
ARS
2026-04-28
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-28
View
DEF 14AProxy Statement
DEF 14A
2026-04-28
View
PRE 14APRE 14A
PRE 14A
2026-04-17
View
8-KCurrent Report
8-K
2026-04-02
View
S-8Employee Stock Plan Registration
S-8
2026-03-23
View
8-KCurrent Report
8-K
2026-03-23
View
Showing 1–15 of 227 filingsForm 4 / 144 hidden· 292 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001842952  |  Exchange: NASDAQ · Healthcare

Context Therapeutics Inc. (NASDAQ: CNTX) has submitted 292 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001842952, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Context Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent Context Therapeutics Inc. 10-K was filed on 2026-03-23 for fiscal year ending 2026. Historical CNTX 10-K annual reports are available from 2021 through 2026.

Investors researching Context Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
OVID SEC Filings →MGNX SEC Filings →WHWK SEC Filings →STTK SEC Filings →ORMP SEC Filings →CNTB SEC Filings →IFRX SEC Filings →KLRS SEC Filings →
→ CNTX Financials→ CNTX Earnings→ CNTX Insider Trades

Frequently Asked Questions

CNTX SEC Filings · 8 questions

Context Therapeutics Inc. (CNTX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 292 filings and access original documents at no cost. Context Therapeutics Inc.'s CIK is 0001842952.

CNTX SEC filingsContext Therapeutics Inc. SEC documentsfind CNTX 10-K